Professor Jon Arch, Dean of the School of Science, presented Pharmacotherapy – The Options at the 12th International Congress on Obesity in Kuala Lumpur, Malaysia

19 March 2014

Professor Arch’s lecture described both the limited pharmaceutical options available to obese patients in most of the world, and how very few US patients use two drugs that have been recently approved in their country, many preferring a 44-year-old drug (phentermine) that has been withdrawn in much of the rest of the world.

He discussed research targeted at brown adipose tissue, which is present in limited amounts in the bodies of obesity sufferers.  To be useful, new drugs will need to increase the amount of brown adipose tissue in obese patients as well activate it to burn off fat. They will have to have advantages over exposing oneself to colder temperatures or eating spicy food, which both activate brown adipose tissue and have not yet been proven to be of benefit in the treatment of obesity.